IP Library Granted Patent US 7,927,368
Granted Patent B2
US 7,927,368 · App. 10/727,667 · Granted Apr 19, 2011

Device viewable under an imaging beam

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,927,368
App. No.
10/727,667
Granted
Apr 19, 2011
Kind
B2
Abstract

The invention provides a stent made from a material operable to perform a stent's desired therapeutic functions, and also made from a material that has a radiopacity that substantially preserves the appearance of the stent when the stent is viewed under a CT imaging beam. Such a stent can allow for follow-up of the stent and the surrounding blood-vessel on CT.

Claims (16)

1. A stent, comprising:

a material having structure to provide three-dimensional visualization of a surrounding tissue when said stent is inserted into said tissue and viewed under an imaging beam,

said stent having:

(i) a single coating layer selected from a group consisting of:

(i) (a) a hydrophilic polymer, (i) (b) a hydrophobic polymer, and (i) (c) a fatty acid polymer, and

(ii) a density enhancing radiologic opacifier embedded into said single coating layer, said single coating layer and said embedded opacifier material together providing a first Hounsfield image density suitable for viewing under a first image modality used during device insertion into a patient, and wherein said density enhancing radiologic opacifier material is configured to elute from said single coating layer so as to provide a second Hounsfield image density suitable for viewing under a second image modality used for subsequent visualization of surrounding tissue, wherein the stent has an image density of less than about 1200 Hounsfield Units.

2. The stent according to claim 1 , wherein said density enhancing radiologic opacifier material comprises a lyophilized iodinated contrast.

3. The stent according to claim 1 , wherein said density enhancing radiologic opacifier material is selected from the group consisting of a robust plastic and a polymeric formulation.

4. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by bulk erosion, such that said stent has increased visibility than said stent prior to elution.

5. The stent of claim 4 , wherein said imaging comprises MR.

6. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by surface erosion, such that said stent has increased visibility when viewed under an imaging beam than said stent prior to elution.

7. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by diffusion, such that said stent has increased visibility when viewed under an imaging beam than said stent prior to elution.

8. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by degradation, such that said stent has increased visibility when viewed under an imaging beam than said stent prior to elution.

9. The stent of claim 4 , wherein said imaging comprises CT.

10. The stent according to claim 1 , wherein the density enhancing radiologic opacifier comprises a lyophilized density enhancing radiologic opacifier.

11. The stent according to claim 1 , wherein the stent has an image density of less than about 400 Hounsfield Units.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2006
From: MURPHY, KIERAN, DR.
To: KIERAN MURPHY LLC
Reel/Frame 018418/0093 →